Mark S Shearman - Net Worth and Insider Trading
Mark S Shearman Net Worth
The estimated net worth of Mark S Shearman is at least $245,846 dollars as of 2024-09-20. Mark S Shearman is the EVP, CHIEF SCIENTIFIC OFFICER of Editas Medicine Inc and owns about 65,559 shares of Editas Medicine Inc (EDIT) stock worth over $245,846. Mark S Shearman is also the Chief Scientific Officer of Applied Genetic Technologies Corp and owns about 0 shares of Applied Genetic Technologies Corp (AGTC) stock worth over $0. Details can be seen in Mark S Shearman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark S Shearman has not made any transactions after 2023-02-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark S Shearman
Mark S Shearman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark S Shearman owns 2 companies in total, including Applied Genetic Technologies Corp (AGTC) , and Editas Medicine Inc (EDIT) .
Click here to see the complete history of Mark S Shearman’s form 4 insider trades.
Insider Ownership Summary of Mark S Shearman
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AGTC | Applied Genetic Technologies Corp | 2018-12-14 | Chief Scientific Officer |
EDIT | Editas Medicine Inc | 2023-02-13 | EVP & Chief Scientific Officer |
Mark S Shearman Latest Holdings Summary
Mark S Shearman currently owns a total of 2 stocks. Among these stocks, Mark S Shearman owns 65,559 shares of Editas Medicine Inc (EDIT) as of February 13, 2023, with a value of $245,846 and a weighting of 100%. Mark S Shearman also owns 0 shares of Applied Genetic Technologies Corp (AGTC) as of December 14, 2018, with a value of $0 and a weighting of 0%.
Latest Holdings of Mark S Shearman
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
EDIT | Editas Medicine Inc | 2023-02-13 | 65,559 | 3.75 | 245,846 |
AGTC | Applied Genetic Technologies Corp | 2018-12-14 | 0 | 0.39 | 0 |
Holding Weightings of Mark S Shearman
Mark S Shearman Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark S Shearman has made a total of 2 transactions in Editas Medicine Inc (EDIT) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Editas Medicine Inc is the sale of 2,790 shares on February 13, 2023, which brought Mark S Shearman around $26,979.
According to the SEC Form 4 filings, Mark S Shearman has made a total of 0 transactions in Applied Genetic Technologies Corp (AGTC) over the past 5 years. The most-recent trade in Applied Genetic Technologies Corp is the sale of 3,000 shares on December 14, 2018, which brought Mark S Shearman around $10,050.
Insider Trading History of Mark S Shearman
- 1
Mark S Shearman Trading Performance
GuruFocus tracks the stock performance after each of Mark S Shearman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark S Shearman is 6.86%. GuruFocus also compares Mark S Shearman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark S Shearman within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark S Shearman's insider trading performs compared to the benchmark.
Performance of Mark S Shearman
Mark S Shearman Ownership Network
Mark S Shearman Owned Company Details
What does Applied Genetic Technologies Corp do?
Who are the key executives at Applied Genetic Technologies Corp?
Mark S Shearman is the Chief Scientific Officer of Applied Genetic Technologies Corp. Other key executives at Applied Genetic Technologies Corp include Chief Medical Officer Susan Schneider , Chief Financial Officer Jonathan I Lieber , and See Remarks Stephen W Potter .
Applied Genetic Technologies Corp (AGTC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Applied Genetic Technologies Corp (AGTC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Applied Genetic Technologies Corp (AGTC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Applied Genetic Technologies Corp (AGTC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Applied Genetic Technologies Corp Insider Transactions
Mark S Shearman Mailing Address
Above is the net worth, insider trading, and ownership report for Mark S Shearman. You might contact Mark S Shearman via mailing address: C/o Applied Genetic Technologies Corp, 11801 Research Drive, Suite D, Alachua Fl 32615.